Target Name: LOC102723560
NCBI ID: G102723560
Review Report on LOC102723560 Target / Biomarker Content of Review Report on LOC102723560 Target / Biomarker
LOC102723560
Other Name(s): LOC102723560 variant X2 | LOC102723560 variant X1 | uncharacterized LOC102723560 | Uncharacterized LOC102723560, transcript variant X2 | Uncharacterized LOC102723560, transcript variant X1

LOC102723560: A Potential Drug Target or Biomarker

LOC102723560, also known as LOC102723560 variant X2, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique genetic variation has led to a unique expression of the gene in various tissues, which could provide valuable insights into its function and the potential benefits of targeting it as a drug or biomarker.

The LOC102723560 gene is located on chromosome 10q34 and has been identified as a candidate gene for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene has been shown to be involved in the development and progression of these diseases, which makes it an attractive target for researchers to investigate.

One of the reasons why LOC102723560 is considered a potential drug target is its unique expression in various tissues. Studies have shown that LOC102723560 is highly expressed in various tissues, including the brain, heart, and pancreas, which are known to be critical for the function and survival of the organism. This suggests that targeting this gene may have therapeutic benefits for these diseases.

Another potential benefit of targeting LOC102723560 is its involvement in the development of cancer. Studies have shown that LOC102723560 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting this gene may have therapeutic benefits for these diseases.

In addition to its potential role in cancer, LOC102723560 has also been shown to be involved in the development and progression of neurodegenerative diseases. Studies have shown that LOC102723560 is highly expressed in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. This suggests that targeting this gene may have therapeutic benefits for these diseases.

Finally, LOC102723560 has also been shown to be involved in the development and progression of autoimmune disorders. Studies have shown that LOC102723560 is highly expressed in various autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. This suggests that targeting this gene may have therapeutic benefits for these diseases.

In conclusion, LOC102723560 is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique expression in various tissues and its involvement in the development and progression of these diseases make it an attractive target for researchers to investigate. Further studies are needed to determine the functional role of LOC102723560 and its potential as a drug or biomarker.

Protein Name: Uncharacterized LOC102723560

The "LOC102723560 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102723560 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102723564 | LOC102723566 | LOC102723568 | LOC102723576 | LOC102723596 | LOC102723639 | LOC102723686 | LOC102723692 | LOC102723724 | LOC102723739 | LOC102723750 | LOC102723769 | LOC102723834 | LOC102723838 | LOC102723850 | LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213 | LOC105369250